Attovia Therapeutics
Biotechnology, Bayside Pkwy, Fremont, , 94538, California, 47071, United States, 11-50 Employees
Phone Number: +16*********
Who is ATTOVIA THERAPEUTICS
Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format...
Read More
-
Headquarters: 47071 Bayside Pkwy, Fremont, California, 94538, United States
-
Date Founded: 2023
-
Employees: 11-50
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8071
Does something look wrong? Fix it. | View contact records from ATTOVIA THERAPEUTICS
Attovia Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Attovia Therapeutics
Answer: Attovia Therapeutics's headquarters are located at Bayside Pkwy, Fremont, , 94538, California, 47071, United States
Answer: Attovia Therapeutics's phone number is +16*********
Answer: Attovia Therapeutics's official website is https://attovia.com
Answer: Attovia Therapeutics's revenue is $50 Million to $100 Million
Answer: Attovia Therapeutics's SIC: 8071
Answer: Attovia Therapeutics has 11-50 employees
Answer: Attovia Therapeutics is in Biotechnology
Answer: Attovia Therapeutics contact info: Phone number: +16********* Website: https://attovia.com
Answer: Attovia is creating a pipeline of biotherapeutics with an initial focus on immune-mediated disease and oncology. We leverage ATTOBODY, a novel biologics platform, to generate small format biparatopic binders that unlock the spatial aspect of target engagement. The biparatopic binding mode of ATTOBODIES translates to picomolar affinity with glue-like off-rates, exquisite specificity, and accelerated target internalization. Their small format and modularity offer fast tissue penetration, ease of engineering into bispecifics, and tunable half-life from hours to weeks. Collectively, these properties of ATTOBODIES expand the addressable target and epitope universe across disease areas and can offer stronger efficacy, faster speed to response, and an improved safety profile compared to traditional approaches. By utilizing our ATTOBODY technology, we will develop novel medicines that target unaddressed elements of disease, as well as offer better efficacy and tolerability. We envision a world where no patient is left behind.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month